Home
Conditions
Non Hodgkin's Lymphoma

Clinical trial condition

Non Hodgkin's Lymphoma

Explore clinical trials studying Non Hodgkin's Lymphoma. Study availability and eligibility vary by location and protocol.

20 public trials 2 recruiting studies

Refine in advanced search Browse all conditions

Non Hodgkin's Lymphoma trial results

Recruiting

Allogenic CD19-targeting CAR-γδT Cell Therapy in R/R NHL

NCT05554939

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations: School of phamaceutical, Tsinghua University Beijing, Beijing Municipality, China

Biotherapeutic Department, Chinese PLA General Hospital Beijing, China

View Trial Details

Recruiting

TRAC and Power3 (SPPL3) Genes Knock-out Allogeneic CD19-targeting CAR-T Cell Therapy in r/r B-NHL

NCT06014073

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: Biotherapeutic Department, Chinese PLA General Hospital Beijing, China

EdiGene Inc Beijing, China

School of Life Sciences, Peking University Beijing, China

View Trial Details

Completed

Pilot Study of Non-Myeloablative, HLA-Matched Allogeneic Stem Cell Transplantation for Pediatric Hematopoietic Malignancies

NCT00013533

Conditions: ALL, AML, Bone Marrow Diseases, +21 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Shorter Course Tacrolimus After Nonmyeloablative, Related Donor BMT With High-dose Posttransplantation Cyclophosphamide

NCT01342289

Conditions: Blood Protein Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +22 more
Locations: Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States

View Trial Details

Completed

Eltrombopag for the Treatment of Immune ThrombocytoPenia (ITP) Secondary to Chronic Lymphoproliferative Disorders (LPDs)

NCT01610180

Conditions: Autoimmune Diseases, Autoimmune Thrombocytopenia, Autoimmune Thrombocytopenic Purpura, +32 more
Locations: Department of Hematology, Ospedale San Bortolo Vicenza, Italy

View Trial Details

Completed

Donor Th2 Cells to Prevent Graft-Versus-Host Disease in Bone Marrow Transplants

NCT00001830

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +28 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Allogeneic Cytokine-induced Killer Immunotherapy for Relapse After Allogeneic Marrow Transplant for Haematological Malignancies

NCT00460694

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Blood Protein Disorders, +35 more
Locations: Singapore General Hospital Singapore

View Trial Details

Completed

Registry Study of T Cell Depleted Allo Non-Myeloablative Stem Cell Transplant

NCT01904175

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +19 more
Locations: Duke University Health System Durham, North Carolina, United States

View Trial Details

Completed

Study of MGCD0103 Given Three-Times Weekly in Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma

NCT00323934

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +12 more
Locations: The Johns Hopkins Hospital Baltimore, Maryland, United States

Princess Margaret Hospital Toronto, Ontario, Canada

Hopital Charles LeMoyne Greenfield Park, Quebec, Canada

View Trial Details

Completed

Phase I Trial of Clofarabine in Combo w/ HD Etoposide & Cyclophosphamide and APBSCT for Pts w/ High-Risk or Refractory NHL

NCT00477945

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: Indiana University Cancer Center Indianapolis, Indiana, United States

View Trial Details

Non Hodgkin's Lymphoma

Non Hodgkin's Lymphoma trial results

Related conditions